Literature DB >> 6867054

Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs.

A D Potthoff, G Ellison, L Nelson.   

Abstract

Groups of rats, acclimated to drinking both water and 10% v/v ethanol were implanted with a variety of slow-release devices containing d-amphetamine (d-amp), nicotine, caffeine, phencyclidine (PCP), secobarbital, LSD, mescaline or haloperidol. Ethanol intake was elevated only during treatment with d-amp or nicotine; none of the other drugs affected ethanol consumption even though the amounts of all drugs released were pharmacologically sufficient to affect behavior. Nicotine treated rats were not simply seeking calories provided by the EtOH solution, since nicotine treatment did not enhance intake of a distinctively flavored solution isocaloric to 10% ethanol. These results support a self-medication model of ethanol intake.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6867054     DOI: 10.1016/0091-3057(83)90269-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  30 in total

1.  Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Authors:  Amir H Rezvani; Susan Slade; Cori Wells; Ann Petro; Lawrence Lumeng; Ting-Kai Li; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Jed E Rose; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

Review 2.  Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

Review 3.  The Impact of Caffeine on the Behavioral Effects of Ethanol Related to Abuse and Addiction: A Review of Animal Studies.

Authors:  Laura López-Cruz; John D Salamone; Mercè Correa
Journal:  J Caffeine Res       Date:  2013-03

4.  Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner.

Authors:  Sheketha R Hauser; Bruk Getachew; Scott M Oster; Ronnie Dhaher; Zheng-Ming Ding; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

Review 5.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 6.  Nicotinic acetylcholine receptors in health and disease.

Authors:  J Lindstrom
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

7.  Repeated exposure of the posterior ventral tegmental area to nicotine increases the sensitivity of local dopamine neurons to the stimulating effects of ethanol.

Authors:  Zheng-Ming Ding; Simon N Katner; Zachary A Rodd; William Truitt; Sheketha R Hauser; Gerald A Deehan; Eric A Engleman; William J McBride
Journal:  Alcohol       Date:  2012-03-25       Impact factor: 2.405

8.  Effects of Nicotine on Alcohol Drinking in Female Mice Selectively Bred for High or Low Alcohol Preference.

Authors:  Marcus M Weera; Molly A Fields; Danielle N Tapp; Nicholas J Grahame; Julia A Chester
Journal:  Alcohol Clin Exp Res       Date:  2018-01-15       Impact factor: 3.455

9.  The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat.

Authors:  David T Chau; Jibran Y Khokhar; Ree Dawson; Jayme Ahmed; Haiyi Xie; Alan I Green
Journal:  Alcohol       Date:  2013-10-17       Impact factor: 2.405

10.  Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats.

Authors:  A D Lê; A Wang; S Harding; W Juzytsch; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.